Ensayos clínicos

8.676 ensayos encontrados

ReclutandoFase 4ClinicalTrials.gov

Cambio a terapia dual con dolutegravir más lamivudina en mujeres transgénero que viven con VIH bajo tratamiento antirretroviral con supresión virológica (TRANS-SWITCH)

IntervencionalInicio: 31 de jul de 2025ID: NCT06967753

CompletadoFase 3ClinicalTrials.gov

A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study

IntervencionalInicio: 1 de nov de 2011ID: NCT01435616

Activo, no reclutaFase 3ClinicalTrials.gov

Ensayo aleatorizado, doble ciego, controlado con placebo y multicéntrico para evaluar el impacto de inclisirán sobre los eventos cardiovasculares adversos mayores en participantes con enfermedad cardiovascular establecida (VICTORION-2 PREVENT)

IntervencionalInicio: 23 de nov de 2021ID: NCT05030428

CompletadoFase 3ClinicalTrials.gov

A 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma

IntervencionalInicio: 1 de feb de 2011ID: NCT01270464

CompletadoClinicalTrials.gov

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

IntervencionalInicio: 1 de jul de 2012ID: NCT01471522

CompletadoFase 3ClinicalTrials.gov

A Double-Blind, Randomized, Multicenter, Placebo-controlled, In-Patient, Maximum 34 Day Study of Levetiracetam Oral Solution (20-50 mg/kg/Day) as Adjunctive Treatment of Refractory Partial Onset Seizures in Pediatric Epileptic Subjects Ranging in Age From 1 Month to Less Than 4 Years of Age

IntervencionalInicio: 1 de oct de 2004ID: NCT00175890

TerminadoFase 3ClinicalTrials.gov

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis (RA) Who Had an Inadequate Response to One or More TNF-α Inhibitors (FLEX V)

IntervencionalInicio: 1 de ene de 2011ID: NCT01202773

CompletadoFase 2ClinicalTrials.gov

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Obinutuzumab in Patients With ISN/RPS 2003 Class III or IV Lupus Nephritis

IntervencionalInicio: 13 de nov de 2015ID: NCT02550652

CompletadoFase 2ClinicalTrials.gov

A Multi-center, Randomized, Double-blind, Placebo and Active-controlled Study With Exploratory Dose-ranging to Investigate the Efficacy and Safety of 16 Weeks Treatment With Subcutaneous (s.c.) QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists

IntervencionalInicio: 1 de dic de 2012ID: NCT01716754

CompletadoFase 3ClinicalTrials.gov

A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination With Metformin in Subjects With Type 2 Diabetes

IntervencionalInicio: 1 de mar de 2009ID: NCT00856284

CompletadoFase 3ClinicalTrials.gov

A Multicentre, Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma (SOURCE)

IntervencionalInicio: 5 de mar de 2018ID: NCT03406078

CompletadoFase 3ClinicalTrials.gov

Atazanavir (BMS-232632) for HIV Infected Individuals Completing Atazanavir Clinical Trials: An Extended Access Study

IntervencionalInicio: 1 de oct de 2002ID: NCT01003990

CompletadoFase 2ClinicalTrials.gov

Ensayo clínico aleatorizado, abierto y de escalada de dosis hasta el desarrollo de rash para evaluar el efecto de Tarceva en combinación con gemcitabina sobre la supervivencia global en pacientes con cáncer de páncreas metastásico

IntervencionalInicio: 1 de may de 2008ID: NCT00652366

CompletadoFase 3ClinicalTrials.gov

Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)

IntervencionalInicio: 1 de mar de 2005ID: NCT00256750

ReclutandoFase 3ClinicalTrials.gov

Un protocolo maestro para estudios de fase 3, aleatorizados, doble ciego, controlados con placebo para investigar la eficacia y seguridad de eloralintide de administración semanal en participantes adultos con apnea obstructiva del sueño de moderada a grave y obesidad o sobrepeso

IntervencionalInicio: 10 de feb de 2026ID: NCT07369011

CompletadoClinicalTrials.gov

Comprehensive Approach for Hypertension Prevention and Control in Argentina

IntervencionalInicio: 1 de jun de 2013ID: NCT01834131

ReclutandoFase 3ClinicalTrials.gov

Estudio de fase 3, aleatorizado, doble ciego y controlado con placebo para investigar la eficacia y seguridad de eloralintide administrado una vez por semana en participantes adultos con obesidad o sobrepeso y diabetes tipo 2

IntervencionalInicio: 15 de dic de 2025ID: NCT07282600

Activo, no reclutaFase 3ClinicalTrials.gov

Estudio de fase 3, aleatorizado, de quimioterapia neoadyuvante sola versus quimioterapia neoadyuvante más nivolumab o nivolumab y BMS-986205, seguido de terapia continua posquirúrgica con nivolumab o nivolumab y BMS-986205 en participantes con cáncer de vejiga con invasión muscular

IntervencionalInicio: 6 de nov de 2018ID: NCT03661320

CompletadoClinicalTrials.gov

PRINCIPAL: A Prospective Observational Study of Real World Treatment Patterns and Treatment Outcomes in Patients With Advanced or Metastatic Renal Cell Carcinoma Receiving Pazopanib

ObservacionalInicio: 19 de jul de 2012ID: NCT01649778

CompletadoClinicalTrials.gov

Survey on Predictors of Discharge from Stroke Units in Argentina

ObservacionalInicio: 15 de nov de 2024ID: NCT06623253